Please Note: This trial is no longer enrolling new participants
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
| Protocol No. | CTO-EAA173 | Scope | National |
|---|---|---|---|
| Principal Investigator | Rafat Abonour | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
